Pulse Biosciences, Inc. (PLSE): R&D Expense
$44.72M
Year ended 2025-12-31
$51.89M
Trailing 12 months to 2026-06-30
+29.0%
3-year compound annual growth
+11.1%
5-year compound annual growth
+35.3%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $44.72M | +38.3% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $32.34M | +16.3% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $27.80M | +33.4% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $20.84M | -27.2% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $28.64M | +8.3% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $26.44M | +5.9% | 2023-03-31, From 2020-01-01 |
| 2019-12-31 | $24.96M | +44.7% | 2022-03-31, From 2019-01-01 |
| 2018-12-31 | $17.25M | +78.9% | 2021-03-12, From 2018-01-01 |
| 2017-12-31 | $9.65M | +75.2% | 2020-03-16, From 2017-01-01 |
| 2016-12-31 | $5.51M | +152.5% | 2019-03-14, From 2016-01-01 |
| 2015-12-31 | $2.18M | n/a | 2018-03-16, From 2015-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Pulse Biosciences, Inc. (PLSE) | 2025-12-31 | $44.72M | +38.3% |
| QTREX Quantum Ltd. (QTEX) | 2025-12-31 | $7.50M | +18.6% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $19.14M | -8.8% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $2.65M | +14.8% |
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | $862.0K | +216.9% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $4.59M | -11.8% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $6.27M | +4.0% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $1.42M | -10.6% |
| SeaStar Medical Holding Corp (ICU) | 2025-12-31 | $7.52M | -17.4% |
Compare PLSE, QTEX, CODX, HRGN side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗